Jens Bedke - Department of Urology and Transplantation Surgery, Klinikum Stuttgart

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 520 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Prognostic Factors for Overall Survival (OS) in Patients Receiving First-line (1L) Nivolumab Plus Ipilimumab (NIVO+IPI) for Advanced/metastatic Renal Cell Carcinoma (arcc) in a Real-World Setting in Germany

J. Bedke, V. Gruenwald, H. Mueller-Huesmann,H. Belz,E. Von Der Heyde, M. Boegemann, A. Strauss, L. Vaz, T. Bluhmki,M. Herber, S. Groetzinger,M-O. Grimm

EUROPEAN UROLOGY (2024): S1844-S1845

引用0浏览0引用

Characterization of Complete Responders to Nivolumab + Gemcitabine-Cisplatin Vs Gemcitabine-Cisplatin Alone and Patients with Lymph Node–only Metastatic Urothelial Carcinoma from the CheckMate 901 Trial

Matt D. Galsky,Guru P. Sonpavde,Thomas Powles,Melanie Claps,Mauricio Burotto,Michael Schenker,Juan Pablo Sade,Aristotelis Bamias,Philippe Beuzeboc,Jens Bedke,Jan Oldenburg,Yuksel Urun,Ding-Wei Ye,Begona Perez Valderrama,Yoshihiko Tomita,Jeiry Filian,Lily Wang,Daniela Purcea, Michiel Simon Van der Heijden

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Nivolumab Plus Cabozantinib Versus Sunitinib for First-Line Treatment of Advanced Renal Cell Carcinoma: Extended Follow-Up from the Phase III Randomised CheckMate 9ER Trial

T. Powles,M. Burotto,B. Escudier,A. B. Apolo,M. T. Bourlon,A. Y. Shah,C. Suarez,C. Porta,C. H. Barrios,M. Richardet,H. Gurney,E. R. Kessler, Y. Tomita,J. Bedke, S. George,C. Scheffold, P. Wang, V. Fedorov,R. J. Motzer,T. K. Choueiri

ESMO OPEN（2024）

引用0浏览0WOS引用

Lenvatinib Plus Pembrolizumab (L+P) Vs Sunitinib (S) in Advanced Renal Cell Carcinoma (arcc): Patterns of Progression and Subsequent Therapy in the CLEAR Trial

Viktor Grunwald,Robert J. Motzer,Daniel Keizman,Jens Bedke,Manuela Schmidinger,Michael D. Staehler,Vsevolod B. Matveev,Saby George,Thomas E. Hutson,Ulka N. Vaishampayan,Jaime R. Merchan,Masatoshi Eto,Sun Young Rha,Tom Waddell,Roberto Sabbatini,Philippe Barthelemy,Joseph E. Burgents,Min Ren, Ian Brown,Toni K. Choueiri

Journal of Clinical Oncologyno. 16_suppl (2024): 4524-4524

引用0浏览0引用

Analysis of the Immunological Markers BTLA, TIM-3, and PD-L1 at the Invasion Front and Tumor Center in Clear Cell Renal Cell Carcinoma

Viktoria Stühler, Bilal Alemi,Steffen Rausch,Arnulf Stenzl,Matthias Schwab,Elke Schaeffeler,Jens Bedke

WORLD JOURNAL OF UROLOGY（2024）

引用0浏览0WOS引用

CREST: Phase III Study of Sasanlimab and Bacillus Calmette-Guérin for Patients with Bacillus Calmette-Guérin-naïve High-Risk Non-Muscle-invasive Bladder Cancer

Gary D Steinberg,Neal D Shore,Joan Palou Redorta,Matthew D Galsky,Jens Bedke,Ja Hyeon Ku, Michal Kretkowski,Hailong Hu,Konstantin Penkov,Jennifer J Vermette,Jamal C Tarazi,Alison E Randall,Kristen J Pierce,Daniel Saltzstein,Thomas B Powles

Future oncology (London, England)（2024）

引用0浏览0WOS引用

Surgical Anatomy of the Bladder

Bastian Amend,Jens Bedke,Arnulf Stenzl

Robotic Urologypp.235-249, (2024)

引用2浏览0引用

Pictorial Essay: Extrapulmonary Tuberculosis

Florian Hagen,Oliver Bachmann, Christoph Berg,Jens Bedke,Siri Goepel,Sascha Kaufmann

ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN（2024）

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn